Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Barbara Vanni
Observed names:
B Vanni,
B. Vanni
Institution:
Instituto Nazionale Tumori Regina Elena
Observed institutions:
Istituti Fisioterapici Ospitalieri,
Instituto Nazionale Tumori Regina Elena
OpenAlex ID:
A5061075428
Skin testing and hypersensitivity reactions to oxaliplatin
2003
·
C. Garufi
, A. Cristaudo
, et al.
·
Annals of Oncology
·
61
Taxanes with anthracyclines as first‐line chemotherapy for metastatic breast carcinoma: Pooled analysis of 2805 patients
2005
·
Emilio Bria
, Diana Giannarelli
, et al.
·
Cancer
·
55
P53 and bcl-2 in colorectal cancer arising in patients under 40 years of age: Distribution and prognostic relevance
2008
·
A. Torsello
, C. Garufi
, et al.
·
European Journal of Cancer
·
34
Randomised phase II study of standard versus chronomodulated CPT-11 plus chronomodulated 5-fluorouracil and folinic acid in advanced colorectal cancer patients
2005
·
Carlo Garufi
, Barbara Vanni
, et al.
·
European Journal of Cancer
·
31
A phase II study of irinotecan plus chronomodulated oxaliplatin, 5-fluorouracil and folinic acid in advanced colorectal cancer patients
2003
·
C Garufi
, E Bria
, et al.
·
British Journal of Cancer
·
21
PDF
Single-agent vinorelbine in pretreated breast cancer patients: comparison of two different schedules.
2004
·
E Terzoli
, C Nisticò
, et al.
·
PubMed
·
13
Weekly Docetaxel in Pretreated Metastatic Breast Cancer Patients: A Phase I-II Study
2005
·
Cecilia Nisticò
, Francesco Cognetti
, et al.
·
Oncology
·
9
Neoadjuvant Chemotherapy for Metastatic Colon Cancer: Too Much Caution and Still Too Much to Be Assessed
2006
·
Carlo Garufi
, Giuseppe Maria Ettorre
, et al.
·
Journal of Clinical Oncology
·
6
High-dose chronomodulated infusion of 5-fluorouracil (5-FU) and folinic acid (FA) (FF5?16) in advanced colorectal cancer patients
2004
·
Edmondo Terzoli
, Carlo Garufi
, et al.
·
Journal of Cancer Research and Clinical Oncology
·
6
Epidermal growth factor gene amplification is not frequent and cannot account for antitumor activity of cetuximab plus chemotherapy in advanced colorectal cancer patients
2006
·
C. Garufi
, M. Mottolese
, et al.
·
Journal of Clinical Oncology
·
5
Evaluation of weekly epirubicin-paclitaxel (EP) cardiotoxicity with serum troponin-t and myoglobin and echocardiography in advanced breast cancer (ABC)
2004
·
C. Nisticò
, E. Bria
, et al.
·
Journal of Clinical Oncology
·
1
Parotid metastases of Merkel cell carcinoma.
2003
·
A Catania
, L Falvo
, et al.
·
PubMed
·
1
Activity and tolerability of mitomycin-C (MMC) and chronomodulated capecitabine (C) in advanced colorecatal cancer (ACC) patients
2006
·
C. Campanella
, B. Vanni
, et al.
·
Journal of Clinical Oncology
Acknowledgement to the Reviewers
2005
·
Chih-Hung Hsu
, Kun-Huei Yeh
, et al.
·
Oncology
PDF
Author Index Vol. 68, 2005
2005
·
Chih-Hung Hsu
, Kun-Huei Yeh
, et al.
·
Oncology
PDF
Evidence for an aggressive biological behaviour of brain metastases in advanced colorectal cancer patients
2004
·
C. Garufi
, B. Vanni
, et al.
·
Journal of Clinical Oncology
[Metastatic breast cancer: is global survival increase a realistic endpoint in phase III clinical trials? Studies on taxanes; studies on trastuzumab].
2004
·
Emilio Bria
, Barbara Vanni
, et al.
·
PubMed
L’infusione cronomodulata
2003
·
C Garufi
, B Vanni
, et al.
Cronoterapia
2001
·
Carlo Garufi
, Anna Maria Aschelter
, et al.
·
Tumori Journal
[Chronotherapy].
2001
·
C Garufi
, A M Aschelter
, et al.
·
PubMed
Show more works
View as search
Works count:
20
Citation count:
243
H-index:
7
I10-index:
6
Year
Topic
Type